ArticleProceedings of the National Academy of Sciences of the United States of America2026

Exploiting the CXCR3/CXCL10 axis overrides tumor immune suppression by enhancing immune trafficking and effector cell priming in HNSCC.

Cheyanne K Shinn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.